Patient: Page 24
-
PharmaVoice Team/PharmaVoice
Risk-Based Monitoring: A New Way to Ensure Quality Data
Denise Myshko The FDA’s new guidance about monitoring provides for remote and risk-based monitoring, which offers a more thoughtful process. What started as a way to make sure data were accurate and reflected the original source, clinical trial monitoring has become time-consuming, expensive, and...
By PharmaVoice Team • Dec. 28, 2013 -
PharmaVoice Team/PharmaVoice
What's in a Game? Better Health Outcomes
Gamification techniques are solving some of healthcare’s most serious problems. Every year, one in four American adults suffers from a diagnosable mental disorder, yet most of them go untreated because the majority of primary-care providers have received little training about mental health risk f...
By PharmaVoice Team • Dec. 28, 2013 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Jessica BruEggeman Changing Health Behavior with Insight and Compassion Passionate and knowledgeable about her belief that changing health behavior can lead to improved health outcomes, Jessica Brueggeman succeeds in making a believer out of anyone who comes within her sphere of...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
David Hahn On the Money with Knowledge and Foresight In a hyper-competitive business climate, success requires constant innovation. For David Hahn, this means constantly improving to meet clients’ expectations. Mr. Hahn has been an integral part of the success of The Medical Affairs Company (TMAC...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
August 5, Medicare Chronic Care Pre-Conference Workshop Hyatt Regency Orange County, Garden Grove, Calif. Opal Events, http://www.opalevents.org/p/92/medicare-chronic-care-pre-conference-workshop August 5-7 Active Pharmaceutical Ingredient (API) and Drug Product Specifications The Hilton Los Ange...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Big Data: It's Not The Volume It's The Value
Big Data: It’s Not The Volume It’s The Value By Robin Robinson The term big data can refer to large volumes of data, or small, unstructured pieces. Most recently, the term references the enormous flow of information that is suddenly available from the many healthcare technology tools that have be...
By PharmaVoice Team • May 29, 2013 -
PharmaVoice Team/PharmaVoice
HBA's 2013 Rising Stars
Lisa Arbogast VP, Life Sciences YourEncore Inc. Lisa brings personal passion to advancing women’s careers and helping all members of her team reach their professional goals.In addition, her leadership benefits community causes and our company. Jacqueline Beagan Head, Global Clinical Trial Manage...
By PharmaVoice Team • April 26, 2013 -
PharmaVoice Team/PharmaVoice
Improving Adherence Out of Disruption
Improving Adherence out of Disruption The industry is on the brink of one of the biggest disruptive changes in marketing history — comprehensive relationships with patients using integrated tools. By Robin Robinson The industry is facing many difficult hurdles in 2013 and beyond, but perhaps none...
By PharmaVoice Team • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
R&D Innovation: A Common Goal
R&D Innovation: A Common Goal By Denise Myshko A new paradigm for drug research is emerging as companies begin to work with nontraditional partners to understand disease, access data and new technologies, and ultimately, find new avenues of research. The challenges pharmaceutical research and...
By PharmaVoice Team • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
Time for A Change
Time for a Change By Taren Grom Disruptive innovation, a term coined by Clayton Christensen, describes a process by which a product or service takes root initially in simple applications at the bottom of a market and then relentlessly moves up market, eventually displacing established competitors...
By PharmaVoice Team • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
The 4th Annual Outsourcing in Clinical Trials East Coast, March 19-20, 2013, will address several key areas, including achieving highest efficiency by forming and maintaining a stable relationship with partners, overcoming difficulties in site management, and successfully challenging the economic...
By PharmaVoice Team • Feb. 27, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
Coming ATTRACTIONS The 2013 Pharmaceutical Market Research Group (PMRG) Annual National Conference, March 10-12, 2013, at the Gaylord National Hotel, National Harbor, M.D., will focus on the intrinsic value that an evolved healthcare marketing researcher must bring to today’s global brands and o...
By PharmaVoice Team • Jan. 25, 2013 -
PharmaVoice Team/PharmaVoice
Crystal Ball: What's Ahead
Getting Down to Business: What’s Ahead in 2013 Thought leaders from all sectors of the industry identify what they believe are the most important business objectives for the life-sciences industry and their companies for 2013 and beyond. They also provide their insights on the strategies/approac...
By PharmaVoice Team • Nov. 13, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Marketing: Marketing Without Wires
Throughout pharma history, marketers have always gone where the consumers are — and where they are today, in growing numbers, is on the mobile Web. An estimated 81% of physicians surveyed say they use a smartphone, while 75% specified using an Apple iPhone, iPad, or iPod, according to the Manhatt...
By PharmaVoice Team • Aug. 31, 2012 -
PharmaVoice Team/PharmaVoice
Hitting the Target with Behavioral Marketing
The concept of behavioral marketing is not new, but with the advent of technology and new marketing tools, the industry is able to connect with its consumers on a very individual level, creating the ability to impact behavior and health outcomes on an almost molecular scale. While data are crucia...
By PharmaVoice Team • Aug. 30, 2012 -
PharmaVoice Team/PharmaVoice
The Marketers
Nancy Beesley HCB Health Timmy Garde Star Group Communications Shannon Hartley Rosetta Mike Innaurato Purdue Pharma Scott Richardson Pfizer Jeff Spanbauer Healthcare Regional Marketing Christopher Tobias, Ph.D. Dudnyk Saru Wade Vertex Pharmaceuticals Steven Walker MedImmune The Marketers Brand Ch...
By PharmaVoice Team • July 28, 2012 -
PharmaVoice Team/PharmaVoice
The Change Agents
Lee Babiss, Ph.D. PPD Jeff Berkowitz Walgreen The Change agents (continued) Kathleen Castore Sanofi US Cathryn Clary, M.D. Ipsen Biopharmaceuticals Marianne Eisenmann Chandler Chicco Companies Leigh Householder GSW Worldwide Amir Kalali, M.D. Quintiles Dale Kummerle, Pharm.D...
By PharmaVoice Team • July 28, 2012 -
PharmaVoice Team/PharmaVoice
It's Time for Mobile: Do You Know Where Your Consumers Are?
By Robin Robinson There are several very solid reasons why the industry should be using mobile technology in its marketing efforts, but the one that stands out above all others is quite simple — mobile is where the consumers are. There are more smartphones than personal computers in the United St...
By PharmaVoice Team • May 29, 2012 -
PharmaVoice Team/PharmaVoice
Postapproval Studies: More Critical and Challenging Than Ever
By Robin Robinson Phase IV data are in high demand by more stakeholders. As the need for postapproval data reaches a critical point, the industry explores the multiple options and struggles to determine which methods are best for collecting and analyzing important data. There are as many ways to ...
By PharmaVoice Team • May 29, 2012 -
PharmaVoice Team/PharmaVoice
Pharma 3.0
As the industry evolves to address a new ecosystem within the complex and global drug development and commercialization arena, companies will need to be open to using new technologies, thinking, and processes to make healthcare more sustainable, affordable, and accessible; improve the efficiency ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Final Phase Goal: Maximize Uptake While Speeding to Launch
In every phase of drug development today, processes are more complex and more costly than ever and the drive to reduce time and expenditure is more critical. In today’s ever-changing marketplace, this holds true especially for the last stages of the process: registration, launch, and postlaunch. ...
By PharmaVoice Team • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the ...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Safety and Pharmacovigilance: A Moving Target
Robin Robinson The industry has always been under extreme scrutiny by regulators and the public, but the current business environment creates even more pressure on the pharmaceutical industry to stay compliant. Regulations and procedures are not only tightening but continually developing and c...
By PharmaVoice Team • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Hitting the Social Comfort Zone
Social Media Carolyn Gretton Pharmaceutical and biotechnology companies are shaking off their hesitance to employ social media tactics by forgoing potential marketing applications in favor of connecting with patients and providers in conversations that engage and inform. Most experts would likely...
By PharmaVoice Team • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Pharma 3.0 Next Steps
Robin Robinson Pharma Expands Disease Categories of 3.0 Efforts Between 2006 and 2009, 24% of Pharma 3.0 initiatives focused first on diabetes and metabolics. In 2010, oncology moved to the top with 15% of the year’s initiatives, and diabetes and metabolics tied for second with immunoscience/...
By PharmaVoice Team • Dec. 22, 2011
Previous
